Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Ahmed Zayed Obeidat MD, PhD

Ahmed Zayed Obeidat MD, PhD profile photo picture

Associate Professor

Institution: Medical College of Wisconsin
Department: Neurology
Division: General
Program: Multiple Sclerosis and Neuro-Ophthalmology

Member of the Center for Immunology
Member of the Neuroscience Research Center
Member of the Wisconsin Institute of NeuroScience (WINS)


I am willing to collaborate on research projects.


Research Experience

  • Adult
  • Female
  • Humans
  • Incidence
  • Infant, Newborn
  • Jordan
  • Male
  • Multiple Sclerosis
  • Neural Tube Defects
  • Clinical Expertise

  • Adult
  • Female
  • Humans
  • Incidence
  • Infant, Newborn
  • Jordan
  • Male
  • Multiple Sclerosis
  • Neural Tube Defects
  • Neuromyelitis Optica
  • Methodologies and Techniques

  • Adult
  • Electrophysiology
  • Humans
  • Incidence
  • Infant, Newborn
  • Jordan
  • Male
  • Motor Neurons
  • Neural Tube Defects
  • Renshaw Cells
  • Synapses
  • Leadership Positions

  • Member. Board of Governors, Consortium of Multiple Sclerosis Centers(CMSC). 02/2016 – Present
  • Member of the Judging Panel for “Dr. Raniyah Ramadan Young Arab Neuroscientist
    Travel Award”, (2015 – Present)
  • Society for Arab Neuroscientists (SfAN) Communication Officer (2014-Present).Responsible for intra-society communications and communication with externalcommittees, supporters, and societies.
  • Chair, Graduate Student Assembly Research Symposium Organizing Committee, 2012.
  • Poster Judge for Biomedical Sciences Ph.D. Program Research Retreat, 8/2010.
  • Appointed to the Board of Directors of Global Music and Wellness (a non-profit organization based in Cincinnati, OH) – current term: January 2018 - January2021
  • Nominated and inducted by the University of Cincinnati Chapter into the Alpha OmegaAlpha Honor Medical Society, 09/2017
  • Selected to serve as a President’s Ambassador at Wright State. 5/2012 – 6/2013.
  • A Nominated Member of Wright State University for the American Association for theAdvancement of Science/ Program for Excellence in Science, 2011 – Present.
  • Elected by Wright State University for membership in The Phi Kappa Phi HonorSociety: Top 10% in each Graduate program, 2010 – Present.
  • Ranked 4th among 315 medical school graduates, Jordan University of Scienceand Technology, Class of 2008.
  • Elected to represent Jordan University of Science and Technology in the “East-WestInitiative,” student leadership forum, held at the Marriott Hotel Amman, Jordan, 6/2008.
  • Selected to represent Jordan University of Science and Technology in the FirstInternational Brain Research Organization (IBRO) – United Arab Emirates neuroscienceschool, Al Ain, UAE, 1/2007.
  • Elected to serve as the “Secretary” for the First International Brain Research Organization(IBRO) – United Arab Emirates neuroscience school, Al Ain, UAE, 1/2007.
  • Elected to represent Jordan University of Science & Technology in the 24th PlenarySession of the Interaction Council, under the patronage of King Abdullah II. Dead Sea, Jordan, 5/2006.
  • Named on the Faculty of Medicine honor list, Top 5% of each class, from 2002 - 2008.
  • Named on the Jordan University of Science and Technology President’s honor list: Top
    1% of students in the university during their first year of general classes, 2002-2003.
  • National (Tawjihi) Certification Exam (National High School Cumulative Exam): Score of96.4%, among the top 100 scores in the nation for the academic year 2001-2002.
  • Participant – AAN Neurology on the Hill, 02/26/2017 – 02/28/2017. Washington D.C.
  • SfAN Executive Committee Member (2010-Present). The committee is responsible fororganizing annual meeting, fundraising, and recruitment.
  • Participant – AAN Neurology on the Hill, 02/25/2018 – 02/27/2018. Washington D.C.
  • Member of the Jordanian Cystic Fibrosis Executive Committee (2005-2009). Helped inthe organization of scientific and non-scientific activities for patients and their families.
  • Invited to serve as the discussion leader for the session of “Interneurons in Health andDisease” during the “Inhibition in the CNS” Gordon Research Conference, Lewiston,ME, 8/2015.
  • Co-Chair - the Consortium of Multiple Sclerosis Centers MS Professionals-in-Training Special Interest Group (MS-PiT), (2016 – Present)
  • Co-Chair of “Presidential Search Committee”. Society for Arab Neuroscientists (2016)
  • International Online Medical Conference Abstract Review Committee, 2008, 2009.
  • Member of Student Board Committee of the 1st and 2nd International OnlineMedical Conference (2008, 2009).
  • Educational Expertise

  • Humans
  • Incidence
  • Jordan
  • Multiple Sclerosis
  • Neural Tube Defects
  • Neuromyelitis Optica
  • Publications (49)

  • Impact of neuromyelitis optica spectrum disorder on employment and income in the United States. (Hjerthen IG, Trápaga Hacker C, Meador W, Obeidat AZ, Horta L, Mateen FJ) Ann Clin Transl Neurol 2024 Apr;11(4):1011-1020 PMID: 38374778 PMCID: PMC11021617 SCOPUS ID: 2-s2.0-85186173891 02/20/2024    
  • Inhibition of CD40L with Frexalimab in Multiple Sclerosis. (Vermersch P, Granziera C, Mao-Draayer Y, Cutter G, Kalbus O, Staikov I, Dufek M, Saubadu S, Bejuit R, Truffinet P, Djukic B, Wallstroem E, Giovannoni G, Frexalimab Phase 2 Trial Group) N Engl J Med 2024 Feb 15;390(7):589-600 PMID: 38354138 SCOPUS ID: 2-s2.0-85185346550 02/14/2024       1 Citation
  • Increased healthcare utilization in the year before multiple sclerosis diagnosis. (Razzak AN, Hernandez RS, Salter A, Obeidat AZ) Mult Scler Relat Disord 2024 Mar;83:105438 PMID: 38242052 SCOPUS ID: 2-s2.0-85183017643 01/20/2024    
  • Time to involve the multiple sclerosis expert community at large when revising the McDonald diagnostic criteria. (Obeidat AZ) Mult Scler Relat Disord 2024 Feb;82:105389 PMID: 38118288 SCOPUS ID: 2-s2.0-85180351134 12/21/2023    
  • Molecular biomarkers and cognitive impairment in multiple sclerosis: A review (Esmaeili S, Obeidat AZ, Zabeti A) Biomarkers in Neuropsychiatry December 2023;9 SCOPUS ID: 2-s2.0-85173250674 12/01/2023    
  • Clinical and radiologic differences between early onset, late onset, and very late onset adult multiple sclerosis. (Palathinkara M, Razzak AN, Ababneh OE, Cairns D, Obeidat AZ) Mult Scler Relat Disord 2023 Dec;80:105132 PMID: 37951095 SCOPUS ID: 2-s2.0-85176602731 11/12/2023       1 Citation
  • Progressive multifocal leukoencephalopathy in patients with chronic kidney disease. (Meylor J, Artunduaga DC, Mendoza M, Hooshmand SI, Obeidat AZ) Neurol Sci 2024 Apr;45(4):1619-1624 PMID: 37950135 SCOPUS ID: 2-s2.0-85176588688 11/11/2023    
  • A closer look at reported colitis in association with multiple sclerosis treatments. (Porwal MH, Obeidat AZ) Mult Scler 2024 Mar;30(3):453-455 PMID: 37897260 SCOPUS ID: 2-s2.0-85175354253 10/29/2023    
  • Identification and management of subclinical disease activity in early multiple sclerosis: a review. (Ontaneda D, Chitnis T, Rammohan K, Obeidat AZ) J Neurol 2024 Apr;271(4):1497-1514 PMID: 37864717 PMCID: PMC10972995 SCOPUS ID: 2-s2.0-85174576757 10/21/2023       3 Citations
  • Multiple sclerosis-related spasticity (Obeidat AZ, Ketchum NC) Handbook of Spasticity: A Practical Approach to Management 15 September 2023:305-315 SCOPUS ID: 2-s2.0-85168297937 09/15/2023    
  • Opinion: The role of the registered dietitian nutritionist in multiple sclerosis care in the United States. (Titcomb TJ, Bostick M, Obeidat AZ) Front Neurol 2023;14:1068358 PMID: 36846127 PMCID: PMC9947712 SCOPUS ID: 2-s2.0-85148631143 02/28/2023    
  • Abrupt onset of severe parkinsonism in a patient with metastatic gastrointestinal stromal tumor receiving treatment with avapritinib: A case report. (Drom C, Schenheit K, Matzke M, Obeidat AZ, Molinaro J, Charlson J, Knight JM) Brain Behav Immun Health 2023 Feb;27:100570 PMID: 36578920 PMCID: PMC9791578 SCOPUS ID: 2-s2.0-85144087911 12/30/2022       1 Citation
  • Author response to comment on: Alopecia in multiple sclerosis patients treated with disease modifying therapies. (Porwal MH, Obeidat AZ) J Cent Nerv Syst Dis 2022;14:11795735221127131 PMID: 36200126 PMCID: PMC9527983 SCOPUS ID: 2-s2.0-85156119120 10/07/2022       1 Citation
  • Visual oscillation effects on dynamic balance control in people with multiple sclerosis. (Riem L, Beardsley SA, Obeidat AZ, Schmit BD) J Neuroeng Rehabil 2022 Aug 17;19(1):90 PMID: 35978431 PMCID: PMC9382748 SCOPUS ID: 2-s2.0-85136056967 08/18/2022    
  • Alopecia in Multiple Sclerosis Patients Treated with Disease Modifying Therapies. (Porwal MH, Salter A, Patel D, Obeidat AZ) J Cent Nerv Syst Dis 2022;14:11795735221109674 PMID: 35769950 PMCID: PMC9234852 SCOPUS ID: 2-s2.0-85156135143 07/01/2022       3 Citations
  • A Targeted Literature Search and Phenomenological Review of Perspectives of People with Multiple Sclerosis and Healthcare Professionals of the Immunology of Disease-Modifying Therapies. (Burtchell J, Clemmons D, Clemmons J, Sabutis T, Rosenberg A, Graves J, Sweeney ML, Kramer J, Ziehn M, Brown B, Weiss JL, Obeidat AZ) Neurol Ther 2022 Sep;11(3):955-979 PMID: 35608740 PMCID: PMC9127487 SCOPUS ID: 2-s2.0-85130685380 05/25/2022       1 Citation
  • Disproportional increase in psoriasis reports in association with B cell depleting therapies in patients with multiple sclerosis. (Porwal MH, Patel D, Maynard M, Obeidat AZ) Mult Scler Relat Disord 2022 Jul;63:103832 PMID: 35512502 SCOPUS ID: 2-s2.0-85129551192 05/06/2022       5 Citations
  • Consensus Curriculum for Fellowship Training in Multiple Sclerosis and Neuroimmunology. (Hua LH, Obeidat AZ, Amezcua L, Cohen JA, Costello K, Dunn J, Gelfand JM, Goldman MD, Hopkins S, Jeffery D, Krieger S, Newsome SD, Shah S, Sicotte NL, Yadav V, Longbrake EE) Neurol Clin Pract 2021 Aug;11(4):352-357 PMID: 34484933 PMCID: PMC8382436 SCOPUS ID: 2-s2.0-85130745391 09/07/2021       1 Citation
  • Clinical Reasoning: A 42-Year-Old Woman With Mysterious Monocytic Meningitis. (Nothem ME, Lee RM, Katz JM, Bergl PA, Obeidat AZ) Neurology 2021 Aug 31;97(9):449-454 PMID: 33947775 SCOPUS ID: 2-s2.0-85116959005 05/06/2021       2 Citations
  • "Peppering the pons": CLIPPERS or myelin oligodendrocyte glycoprotein associated disease? (Obeidat AZ, Block AN, Hooshmand SI) Mult Scler Relat Disord 2021 Jun;51:102874 PMID: 33714127 SCOPUS ID: 2-s2.0-85102657644 03/14/2021       7 Citations
  • A national telemedicine program in the Kingdom of Jordan - Editorial. (Obeidat AZ, El-Salem K) Ann Med Surg (Lond) 2021 Feb;62:145-149 PMID: 33520212 PMCID: PMC7820302 SCOPUS ID: 2-s2.0-85099623573 02/02/2021       10 Citations
  • A national telemedicine program in the Kingdom of Jordan – Editorial (Obeidat AZ, El-Salem K) Annals of Medicine and Surgery February 2021;62:145-149 SCOPUS ID: 2-s2.0-85099623573 02/01/2021       10 Citations
  • Comparison of the Efficacy and Safety of Anti-CD20 B Cells Depleting Drugs in Multiple Sclerosis. (Cotchett KR, Dittel BN, Obeidat AZ) Mult Scler Relat Disord 2021 Apr;49:102787 PMID: 33516134 PMCID: PMC9246073 SCOPUS ID: 2-s2.0-85099794165 01/31/2021       26 Citations
  • Serum vitamin d inversely correlates with depression scores in people with multiple sclerosis. (El-Salem K, Khalil H, Al-Sharman A, Al-Mistarehi AH, Yassin A, Alhayk KA, Qawasmeh MA, Bashayreh SY, Kofahi RM, Obeidat AZ) Mult Scler Relat Disord 2021 Feb;48:102732 PMID: 33422916 SCOPUS ID: 2-s2.0-85098946446 01/11/2021       11 Citations
  • Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study. (Naismith RT, Bermel RA, Coffey CS, Goodman AD, Fedler J, Kearney M, Klawiter EC, Nakamura K, Narayanan S, Goebel C, Yankey J, Klingner E, Fox RJ, SPRINT-MS investigators) Neurology 2021 Jan 26;96(4):e491-e500 PMID: 33268562 PMCID: PMC7905793 SCOPUS ID: 2-s2.0-85100445479 12/04/2020       27 Citations
  • Peripheral Neuropathy as a Complication of SARS-Cov-2. (Bureau BL, Obeidat A, Dhariwal MS, Jha P) Cureus 2020 Nov 12;12(11):e11452 PMID: 33214969 PMCID: PMC7673277 11/21/2020    
  • Teaching NeuroImages: Cytotoxic Lesion of the Corpus Callosum Secondary to Influenza A. (Hooshmand SI, Chow K, Obeidat AZ) Neurology 2021 Mar 23;96(12):e1697-e1698 PMID: 32928971 SCOPUS ID: 2-s2.0-85103473281 09/16/2020       1 Citation
  • Outcomes and future directions for neuroimmunology/multiple sclerosis fellowship training: Survey of recent trainees (Hua LH, Obeidat AZ, Longbrake EE) Multiple Sclerosis and Related Disorders September 2020;44 SCOPUS ID: 2-s2.0-85086562755 09/01/2020       3 Citations
  • Outcomes and future directions for neuroimmunology/multiple sclerosis fellowship training: Survey of recent trainees. (Hua LH, Obeidat AZ, Longbrake EE) Mult Scler Relat Disord 2020 Sep;44:102296 PMID: 32585616 PMCID: PMC8023409 SCOPUS ID: 2-s2.0-85086562755 06/26/2020       3 Citations
  • Anti-myelin oligodendrocyte glycoprotein (MOG) associated disease masquerading as prolonged intractable nausea and vomiting. (Block A, Champeau D, Carlson C, Helms A, Obeidat AZ) Mult Scler Relat Disord 2020 Sep;44:102308 PMID: 32575025 SCOPUS ID: 2-s2.0-85086658271 06/24/2020       3 Citations
  • Risk factors for seizures after intracerebral hemorrhage: Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) Study (Kwon SY, Obeidat AZ, Sekar P, Moomaw CJ, Osborne J, Testai FD, Koch S, Lowe MR, Demel S, Coleman ER, Flaherty M, Woo D) Clinical Neurology and Neurosurgery May 2020;192 SCOPUS ID: 2-s2.0-85079198313 05/01/2020       15 Citations
  • Education Research: Multiple sclerosis and neuroimmunology fellowship training status in the United States. (Obeidat AZ, Jassam YN, Hua LH, Cutter G, Ford CC, Halper J, Lisak RP, Sicotte NL, Longbrake EE) Neurology 2020 Mar 17;94(11):495-500 PMID: 32107321 PMCID: PMC9246053 SCOPUS ID: 2-s2.0-85082096206 02/29/2020       3 Citations
  • Risk factors for seizures after intracerebral hemorrhage: Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) Study. (Kwon SY, Obeidat AZ, Sekar P, Moomaw CJ, Osborne J, Testai FD, Koch S, Lowe MR, Demel S, Coleman ER, Flaherty M, Woo D) Clin Neurol Neurosurg 2020 May;192:105731 PMID: 32062309 PMCID: PMC7183434 SCOPUS ID: 2-s2.0-85079198313 02/18/2020       15 Citations
  • EBNA1, EBNA2, and EBNA3 link Epstein-Barr virus and hypovitaminosis D in multiple sclerosis pathogenesis. (Marcucci SB, Obeidat AZ) J Neuroimmunol 2020 Feb 15;339:577116 PMID: 31805475 SCOPUS ID: 2-s2.0-85075733265 12/06/2019       16 Citations
  • Time Is Brain and Spine. (Obeidat AZ) JAMA Neurol 2019 May 01;76(5):623 PMID: 30830163 SCOPUS ID: 2-s2.0-85062362641 03/05/2019    
  • A case of fatal invasive aspergillosis in a patient with neurosarcoidosis treated with infliximab. (Van Sanford C, Obeidat AZ, Hagen M, Zabeti A) Int J Neurosci 2019 Jun;129(6):619-622 PMID: 30430892 SCOPUS ID: 2-s2.0-85057625687 11/16/2018       3 Citations
  • Telemedicine in Neurological Disorders: Opportunities and Challenges. (Chirra M, Marsili L, Wattley L, Sokol LL, Keeling E, Maule S, Sobrero G, Artusi CA, Romagnolo A, Zibetti M, Lopiano L, Espay AJ, Obeidat AZ, Merola A) Telemed J E Health 2019 Jul;25(7):541-550 PMID: 30136898 PMCID: PMC6664824 SCOPUS ID: 2-s2.0-85068907659 08/24/2018       83 Citations
  • Balloons of Hope. (Obeidat AZ, Al-Khun N) Perm J 2018;22:18-024 PMID: 30010537 PMCID: PMC6047848 SCOPUS ID: 2-s2.0-85059794972 07/17/2018    
  • Cocaine as a potential trigger for Neuromyelitis Optica. (Obeidat AZ) J Neurol Sci 2018 Jul 15;390:99-101 PMID: 29801917 SCOPUS ID: 2-s2.0-85045580798 05/29/2018       2 Citations
  • The unseen but felt. (Al-Khun N, Obeidat AZ) Neurology 2018 Feb 27;90(9):428 PMID: 29483314 SCOPUS ID: 2-s2.0-85069865963 02/28/2018    
  • Fragile Scream (Ahmed Z. Obeidat) Neurology Neurology Feb 2018, 90 (9) 427; DOI: 10.1212/WNL.0000000000005015 02/27/2018    
  • Teaching NeuroImages: Crying thalamus: Manifestation of acute ischemic stroke. (Obeidat AZ, Broderick JP) Neurology 2017 Feb 28;88(9):e72-e73 PMID: 28242856 PMCID: PMC5331865 SCOPUS ID: 2-s2.0-85014070512 03/01/2017    
  • Concurrent Dawson's Fingers and Area Postrema Lesion in a Mixed Neuroimmune Disorder. (Obeidat AZ, Jacob C, Zabeti A) Can J Neurol Sci 2017 Jul;44(4):452-454 PMID: 28091334 SCOPUS ID: 2-s2.0-85026744550 01/17/2017    
  • Her Glistening Eyes. (Obeidat AZ) Perm J 2016;20(4):15-227 PMID: 27668451 PMCID: PMC5101105 SCOPUS ID: 2-s2.0-85027496076 09/27/2016    
  • Disconnection. (Obeidat A) Perm J 2016;20(3):15-165 PMID: 27352419 PMCID: PMC4991925 SCOPUS ID: 2-s2.0-85014892307 06/29/2016    
  • John F. Kurtzke, MD (1926-2015). (Obeidat AZ) Neuroepidemiology 2016;46(2):118-9 PMID: 26784580 SCOPUS ID: 2-s2.0-84955609729 01/20/2016    
  • Modulation of motoneuron firing by recurrent inhibition in the adult rat in vivo. (Obeidat AZ, Nardelli P, Powers RK, Cope TC) J Neurophysiol 2014 Nov 01;112(9):2302-15 PMID: 25122713 PMCID: PMC4274916 SCOPUS ID: 2-s2.0-84908432861 08/15/2014       8 Citations
  • Effect of folic acid fortification on the incidence of neural tube defects. (Amarin ZO, Obeidat AZ) Paediatr Perinat Epidemiol 2010 Jul 01;24(4):349-51 PMID: 20618724 SCOPUS ID: 2-s2.0-77953226778 07/14/2010       35 Citations
  • Neural tube defects in the north of Jordan: is there a seasonal variation? (Obeidat AZ, Amarin Z) J Child Neurol 2010 Jul;25(7):864-6 PMID: 19779206 SCOPUS ID: 2-s2.0-77954417386 09/26/2009       9 Citations
  • Last update: 02/24/2024